Walmart will replace British drugmaker AstraZeneca in the Nasdaq-100 Index on January 20, the exchange operator said on ...
A protocol of KDIGO-recommended strategies in high-risk patients significantly reduces moderate-to-severe acute kidney injury ...
A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) levels and cardiovascular ...
(Bloomberg) -- Walmart Inc. will join the Nasdaq 100 Index, replacing AstraZeneca Plc, Nasdaq Global Indexes said Friday. The ...
Walmart is set to join the Nasdaq-100 Index, replacing British pharmaceutical giant AstraZeneca, as part of an index ...
Nasdaq (Nasdaq: NDAQ) today announced that Walmart Inc. (Nasdaq: WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal Weighted™ Index (NDXE™), and the Nasdaq-100 Ex-Tech ...
Parabilis Medicines raised $305 million in a Series F round led by RA Capital, Fidelity and Janus Henderson, with crossover ...
It’s possible that events in 2026, such as local elections in May, could push up gilt yields if investors view government ...
In the past three weeks, a flurry of licensing deals with Chinese biotechs were announced featuring AbbVie, AstraZeneca, ...
Zacks.com on MSN
J&J Strikes Drug Pricing Deal With Trump, Gets Tariff Reprieve
JNJ cuts U.S. drug prices under a Trump deal, gains a tariff reprieve, and accelerates a $55 billion push to expand domestic ...
With Johnson & Johnson’s participation, 15 of 17 companies contacted by the administration over the summer have now signed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback